Metformin fails to improve insulin resistance in type 1 diabetes

A 26-week trial reveals that metformin, long viewed as a promising add-on therapy, lowers insulin needs but leaves tissue-level insulin resistance unchanged.

Study: Effect of metformin on insulin resistance in adults with type 1…